PATH

UiPath, Inc. (PATH)

Technology • Software - Infrastructure

StockNYSEUnited StatesUS90364P1057

13.11 USD -0.23% today Updated 12 Nov 2026 21:08

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by UiPath, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 12 Nov 2026 21:08. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 03 Dec 2026 in 20 days · 16:00 · estimate 0.19

Last results 0.15 vs 0.15 estimated 03 Sep 2026 · Beat +1.6%

Beat the estimate 11 of 12 1 missed · 0 in line

Average surprise +28.1% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
03 Dec 2026 16:00	0.19	—	—	Upcoming
03 Sep 2026 16:00	0.15	0.15	+1.6%	Beat
28 May 2026 16:00	0.16	0.15	-5.5%	Miss
11 Mar 2026 16:00	0.25	0.30	+17.8%	Beat
03 Dec 2025 16:00	0.15	0.16	+9.6%	Beat
04 Sep 2025 16:00	0.08	0.15	+79.8%	Beat
29 May 2025 16:00	0.10	0.11	+7.2%	Beat
12 Mar 2025 16:00	0.19	0.26	+34.0%	Beat
05 Dec 2024 16:00	0.07	0.11	+47.9%	Beat
05 Sep 2024 16:00	0.03	0.04	+21.6%	Beat
29 May 2024 16:00	0.12	0.13	+11.7%	Beat
13 Mar 2024 16:00	0.16	0.22	+39.3%	Beat
30 Nov 2023 16:00	0.07	0.12	+72.4%	Beat
05 Sep 2023 22:00	0.03	0.09	+172.5%	Beat
24 May 2023 16:00	0.02	0.11	+374.8%	Beat
15 Mar 2023 16:00	0.07	0.15	+129.8%	Beat
01 Dec 2022 16:00	-0.01	0.05	+448.2%	Beat
06 Sep 2022 16:00	-0.11	-0.02	+82.0%	Beat
01 Jun 2022 16:00	-0.06	-0.03	+45.6%	Beat
30 Mar 2022 16:00	0.03	0.05	+77.9%	Beat
08 Dec 2021 16:00	-0.04	—	+100.0%	—
07 Sep 2021 16:00	-0.06	0.01	+117.5%	Beat
08 Jun 2021 16:00	-0.05	0.02	+142.8%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2026	1.6B	+12.7%	282.3M	17.5%	0.52	+500.0%	352.2M
2025	1.4B	+9.3%	-73.7M	-5.2%	-0.13	+18.8%	305.6M
2024	1.3B	+23.6%	-89.9M	-6.9%	-0.16	+73.3%	291.7M
2023	1.1B	—	-328.4M	-31.0%	-0.60	—	-33.8M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
12 Nov 2026	12.94	13.26	12.72	13.11	-0.23%	11,894,996
11 Nov 2026	12.95	13.20	12.86	13.14	+2.42%	16,153,500
10 Nov 2026	12.85	12.85	12.42	12.83	-1.16%	28,665,200
09 Nov 2026	12.93	13.12	12.85	12.98	-0.15%	19,996,400
06 Nov 2026	12.97	13.18	12.79	13.00	-0.08%	17,862,100
05 Nov 2026	13.42	13.44	12.91	13.01	-3.70%	24,934,800
04 Nov 2026	13.20	13.83	13.20	13.51	+2.89%	17,764,000
03 Nov 2026	13.14	13.32	12.84	13.13	-1.57%	18,501,200
02 Nov 2026	13.70	13.80	13.26	13.34	-2.84%	20,349,500
30 Oct 2026	13.75	14.03	13.53	13.73	-0.36%	19,249,600
00 Mon 0000	157.29	236.48	315.67	394.86	+0.00%	000,000
00 Mon 0000	553.24	632.43	711.62	790.81	+0.00%	000,000
00 Mon 0000	49.19	128.38	207.57	286.76	+0.00%	000,000
1,254 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Fastly vs. UiPath: Which Artificial Intelligence Stock Is a Better Buy Going into 2027? (opens in a new tab) Motley Fool · 13 Nov 2026 02:44
Should Gemini Healthcare Tie Up Require Action From UiPath (PATH) Investors? (opens in a new tab) Simply Wall St. · 12 Nov 2026 01:18
UiPath (PATH) Could Be 40% Undervalued Following Gemini For Healthcare Launch (opens in a new tab) Simply Wall St. · 11 Nov 2026 20:08
UiPath (PATH) Stock Looks Cheap Based On Future Cash Flow (opens in a new tab) Simply Wall St. · 11 Nov 2026 19:12
UiPath (PATH) Declines More Than Market: Some Information for Investors (opens in a new tab) Zacks · 10 Nov 2026 21:45
UiPath Joins Google Cloud's Gemini For Healthcare As Launch Partner — Enables AI-Powered Workflow Automation (opens in a new tab) Stocktwits · 10 Nov 2026 16:43
UiPath Accelerates Enterprise AI Transformation with Google Cloud’s Gemini for Healthcare (opens in a new tab) 10 Nov 2026 13:30
UiPath: Becoming A Better Business Only Brought It To Fair Value (opens in a new tab) SeekingAlpha · 09 Nov 2026 07:13
UiPath: AI Potential Is Promising, But The Growth Needs To Accelerate (opens in a new tab) SeekingAlpha · 09 Nov 2026 00:54
UiPath Named a Leader in Everest Group's 2026 Agentic Process Automation Platform and Full Suite APAP PEAK Matrix® Assessments (opens in a new tab) 05 Nov 2026 21:30
UiPath Announces Third Quarter Fiscal 2027 Financial Results Conference Call (opens in a new tab) 05 Nov 2026 21:10
UiPath: AI Disruption Fears Are Overshadowing A Profitable Compounder (opens in a new tab) SeekingAlpha · 04 Nov 2026 18:12
Is Most-Watched Stock UiPath, Inc. (PATH) Worth Betting on Now? (opens in a new tab) Zacks · 04 Nov 2026 13:00
UiPath vs. SentinelOne: Which Technology Stock Is a Better Buy for 2027? (opens in a new tab) Motley Fool · 02 Nov 2026 22:16
UiPath (PATH) Falls More Steeply Than Broader Market: What Investors Need to Know (opens in a new tab) Zacks · 02 Nov 2026 21:45

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 13.14 USD
Market cap: 6.8B
Exchange: NYSE
Country: United States
Sector: Technology
Industry: Software - Infrastructure
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	25.0 / 25	Revenue growth of 15.0% a year
Quality Return on equity, net margin and how stable the margins are.	16.7 / 25	ROE of 20%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	20.0 / 20	Net debt is -6.5× EBITDA Free cash flow yield of 6.9%
Valuation Free cash flow yield and the P/E against its sector.	15.0 / 15	P/E 19.6 against 30.4 for its sector
Analysts How far the analysts' average target is from today's price.	9.2 / 10	Analysts' target is +18% from the price

Total debt has risen three years in a row

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	19.61×	Fair	30.41×
P/E (forward)	14.25×	Good	16.48×
Price / book	3.51×	Weak	4.16×
Price / sales	3.98×	Fair	4.03×
EV / EBITDA	30.57×	Weak	16.35×
Free cash flow yield	6.9%	Good	3%

Quality
Figure	Value	Reading	Sector median
Gross margin	82.6%	Good	49.3%
Operating margin	9.4%	Fair	10.2%
Net margin	21%	Good	7.4%
Return on equity	20%	Good	11.9%
Return on assets	3.7%	Fair	4.6%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	15%	Good	8.3%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.04×	Good	0.28×
Net debt / EBITDA	-6.52×	Good	0.06×
Current ratio	2.39×	Good	2.03×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow PATH and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in